% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • yassen_gregorivich yassen_gregorivich Oct 17, 2012 9:14 AM Flag

    Approval equates to $1.8B or $72/share = $701.60/share value

    Yeah, but if only half the patients use the treatment then you can only count half that revenue. Of course the P/E is light, so bump that to 20.

    New price per share value is $701.60 based on a totally different set of calculations.

1.58+0.09(+6.04%)Jul 1 4:00 PMEDT